Solid Biosciences Inc.
SLDB
$7.26
$0.212.98%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 22.52% | -0.87% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.80% | 15.27% | |||
| Operating Income | -2.80% | -15.27% | |||
| Income Before Tax | -8.76% | -15.95% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -8.76% | -15.95% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -8.76% | -15.95% | |||
| EBIT | -2.80% | -15.27% | |||
| EBITDA | -2.63% | -15.43% | |||
| EPS Basic | -8.42% | -15.59% | |||
| Normalized Basic EPS | -8.42% | -15.60% | |||
| EPS Diluted | -8.42% | -15.59% | |||
| Normalized Diluted EPS | -8.42% | -15.60% | |||
| Average Basic Shares Outstanding | 0.33% | 0.29% | |||
| Average Diluted Shares Outstanding | 0.33% | 0.29% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||